Based on our data and previous research, increased expression of C1QA and C1QB could to be involved in pathogenesis and lethality of COVID-19, and could be considered a molecular marker of milder cases, and stimulation of their expression could be a possible option for therapeutic intervention. This evidence concerns the gene C1QB and COVID-19.